PT3487491T - Composições para melhorar a atividade cerebral - Google Patents

Composições para melhorar a atividade cerebral

Info

Publication number
PT3487491T
PT3487491T PT178217188T PT17821718T PT3487491T PT 3487491 T PT3487491 T PT 3487491T PT 178217188 T PT178217188 T PT 178217188T PT 17821718 T PT17821718 T PT 17821718T PT 3487491 T PT3487491 T PT 3487491T
Authority
PT
Portugal
Prior art keywords
compositions
brain activity
enhancing brain
enhancing
activity
Prior art date
Application number
PT178217188T
Other languages
English (en)
Original Assignee
Nektium Pharma S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektium Pharma S L filed Critical Nektium Pharma S L
Publication of PT3487491T publication Critical patent/PT3487491T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/89Cyperaceae (Sedge family)
    • A61K36/8905Cyperus (flatsedge)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/22Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/37Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PT178217188T 2016-07-19 2017-07-19 Composições para melhorar a atividade cerebral PT3487491T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15/214,263 US10537604B2 (en) 2016-07-19 2016-07-19 Compositions for enhancing brain activity

Publications (1)

Publication Number Publication Date
PT3487491T true PT3487491T (pt) 2021-02-19

Family

ID=60812097

Family Applications (1)

Application Number Title Priority Date Filing Date
PT178217188T PT3487491T (pt) 2016-07-19 2017-07-19 Composições para melhorar a atividade cerebral

Country Status (14)

Country Link
US (3) US10537604B2 (pt)
EP (2) EP3795150A1 (pt)
JP (2) JP7059201B2 (pt)
KR (3) KR102539374B1 (pt)
AU (1) AU2017306652A1 (pt)
CA (1) CA3030807A1 (pt)
CL (1) CL2019000114A1 (pt)
DE (1) DE17821718T1 (pt)
DK (1) DK3487491T3 (pt)
ES (1) ES2855674T3 (pt)
PL (1) PL3487491T3 (pt)
PT (1) PT3487491T (pt)
RS (1) RS61490B1 (pt)
WO (1) WO2018025080A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11376294B2 (en) 2016-07-19 2022-07-05 Nektium Pharma S.L. Mangiferin-containing compositions for improving sports performance
US10874708B2 (en) * 2017-01-10 2020-12-29 Nektium Pharma, S.L. Compositions for reducing appetite and craving, increasing satiety, enhancing mood, and reducing stress
EA202191594A1 (ru) * 2018-12-07 2022-01-20 Нектиум Фарма, С.Л. Растительные композиции, содержащие мангиферин, для повышения спортивной работоспособности
KR102328028B1 (ko) * 2021-07-01 2021-11-17 (주)모노랩스 집중력 향상용 젤리형 조성물
IT202100028997A1 (it) 2021-11-16 2023-05-16 C I A M S R L Composizioni utili per ridurre il declino cognitivo in animali da compagnia

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2082170B (en) 1980-07-16 1984-03-28 Vnii Lekarstvenny Process for preparing mangiferin
US4436732A (en) 1981-10-26 1984-03-13 Vichkanova Serafima A Medicated compound for treating diseases infected by virus of the herpes group
ES2111500B1 (es) 1996-08-22 1998-07-16 Coret Monros Salvador Proceso para la obtencion de una composicion alimenticia a base de chufa y platano.
EP1140123A4 (en) 1999-11-12 2006-03-15 Karen M Slimak USE OF TROPICAL ROOTS IN EFFECTIVE INTERVENTION STRATEGIES FOR TREATING DIFFICULT AND COMPLEX CASES AND CHRONIC DISEASES
US6613797B2 (en) 1999-12-02 2003-09-02 Interlab, Inc. Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins
RU2176516C1 (ru) 2000-11-17 2001-12-10 Чернов Юрий Николаевич Адаптоген стресс-корректор
RU2197259C1 (ru) 2001-07-18 2003-01-27 Чернов Юрий Николаевич Антидиабетическое средство
US7250181B2 (en) * 2005-01-19 2007-07-31 Natreon, Inc. Polyherbal compositions and methods for treating viral infections
CN101003558A (zh) 2006-10-17 2007-07-25 中国人民解放军第二军医大学 芒果苷类化合物以及其制备方法和在医药领域的应用
WO2008061480A1 (en) 2006-11-24 2008-05-29 Hainan Deze Drug Research Co., Ltd Novel mangiferin calcium salts, the method for its preparation and its use
CN101848922B (zh) 2007-11-22 2013-01-02 海南德泽药物研究有限公司 一种新的芒果苷钙盐及其制备方法与用途
EP2220103B1 (en) 2007-11-22 2015-04-08 Hainan Deze Drug Research Co., Ltd Novel mangiferin calcium salts, the method for its preparation and its use
FR2926726B1 (fr) 2008-01-28 2010-04-02 Limousine D Applic Biolog Dite Utilisation d'un actif issu de cyperus esculentus pour son action anti-age.
FR2929945B1 (fr) 2008-04-11 2010-09-03 Inst Rech Developpement Ird Procede d'extraction de mangiferine et d'isomanfigerine.
CN101269161B (zh) 2008-05-20 2011-12-07 贺州学院 一种从荸荠皮中提取总黄酮的工艺
CN101270230B (zh) 2008-05-20 2012-06-20 贺州学院 一种超声波辅助提取荸荠皮天然棕色素的方法
GB2464700B (en) 2008-10-22 2012-11-28 Univ Plymouth A method of colouring tin and tin-containing articles
CN101732360B (zh) 2008-11-14 2011-09-07 郑州豫密药业股份有限公司 中药丸剂的打光方法
CN101921270A (zh) 2009-06-16 2010-12-22 海南德泽药物研究有限公司 一种芒果苷小檗碱盐及其制备方法与用途
CN101731710B (zh) 2010-01-17 2012-11-28 李国平 一种油莎豆饮料及其制作方法
CN103191141B (zh) 2012-01-05 2014-10-22 昆明制药集团股份有限公司 3-甲氧基芒果苷在制备治疗脑卒中后抑郁药物中的应用
GB201205856D0 (en) 2012-04-02 2012-05-16 Randall Jeremy A P Food supplement to support brain function
CN102920696B (zh) 2012-09-27 2015-03-18 戴好富 芒果苷类化合物或芒果提取物用作胰脂肪酶抑制剂、制备防治肥胖的药物或食品的应用
US20140220220A1 (en) 2013-02-05 2014-08-07 Nutso, Llc Tiger nut foodstuff and systems and methods for processing tiger nut foodstuffs
CN104557892B (zh) 2013-10-14 2018-01-02 北京大学 一种芒果苷单位点衍生物及其制备方法和用途
BR112018073483B1 (pt) 2016-05-21 2022-08-23 Laila Impex Suplementos e composições dietéticas para a melhoria do desempenho físico e dos níveis de energia

Also Published As

Publication number Publication date
CL2019000114A1 (es) 2019-06-14
WO2018025080A2 (en) 2018-02-08
US20180021397A1 (en) 2018-01-25
DK3487491T3 (da) 2021-01-11
WO2018025080A3 (en) 2018-04-12
JP7059201B2 (ja) 2022-04-25
US10537604B2 (en) 2020-01-21
CA3030807A1 (en) 2018-02-08
ES2855674T3 (es) 2021-09-24
PL3487491T3 (pl) 2021-04-19
JP2019529333A (ja) 2019-10-17
KR102439451B1 (ko) 2022-09-01
KR102539374B1 (ko) 2023-06-01
EP3487491A2 (en) 2019-05-29
KR20220132037A (ko) 2022-09-29
AU2017306652A1 (en) 2019-01-31
EP3795150A1 (en) 2021-03-24
KR20190030642A (ko) 2019-03-22
JP7461066B2 (ja) 2024-04-03
DE17821718T1 (de) 2020-08-20
JP2022092000A (ja) 2022-06-21
US20220023376A1 (en) 2022-01-27
EP3487491B1 (en) 2020-12-16
RS61490B1 (sr) 2021-03-31
KR20210130845A (ko) 2021-11-01
US20190151397A1 (en) 2019-05-23

Similar Documents

Publication Publication Date Title
DK3478217T3 (en) Historisk scanningsreference for intraorale scanninger
EP3466435C0 (en) BRAIN FUNCTION IMPROVING AGENT
LT3426226T (lt) Oftalmologinė kompozicija
HK1257500A1 (zh) 包含尿石素化合物的組合物
GB201601572D0 (en) NO containing compositions
SG11201808685SA (en) Composition for improving brain function for neonates
RS61490B1 (sr) Kompozicije za pojačanje moždane aktivnosti
HUE043899T2 (hu) Készítmény az egészséges szemhez
EP3305311A4 (en) Brain function-protecting agent
HK1247088A1 (zh) 腦機能改善組合物
IL258370A (en) Oxa-diazaspiro compounds with analgesic activity
GB201610464D0 (en) Catalytic compositions
AU365783S (en) Bed assembly
GB201503926D0 (en) Compounds
GB201501115D0 (en) Compounds
SI3490577T1 (sl) Kožni sestavki, ki obsegajo turmerone
PT3445377T (pt) Composições para a pele
PT3365345T (pt) Composto de oxa- azaespiro tendo atividade contra a dor
GB201516421D0 (en) Improved Hydrogel Compositions
GB201520189D0 (en) Compound for use
GB201519549D0 (en) Compounds
GB201517841D0 (en) NO containing compositions
GB201508453D0 (en) Compounds
GB201508454D0 (en) Compounds
GB201505670D0 (en) Compounds